本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Milestone Pharmaceuticals Inc.

0.9582
-0.0219-2.23%
成交量:193.49萬
成交額:185.94萬
市值:1.19億
市盈率:-1.42
高:1.04
開:0.9920
低:0.9401
收:0.9801
52周最高:3.06
52周最低:0.9401
股本:1.24億
流通股本:1.06億
量比:1.66
換手率:1.82%
股息:- -
股息率:- -
每股收益(TTM):-0.6748
每股收益(LYR):-0.7517
淨資產收益率:-35522.62%
總資產收益率:-42.78%
市淨率:6.52
市盈率(LYR):-1.27

資料載入中...

2021/03/30

重要事件披露

8-K - Current report
2021/03/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/26

重要事件披露

8-K - Current report
2020/10/23

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/09/22

重要事件披露

8-K - Current report
2020/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/29

重要事件披露

8-K - Current report